Trade Group Study: Hundreds of Rare Disease Drugs in Development

According to a new report, the drug development pipeline is innovative and robust, with a high percentage of potential first-in-class medicines targeting targeting diseases with limited treatment options, including a number of rare diseases.The post Trade Group Study: Hundreds of Rare Disease Drugs in Development appeared first on Highlight HEALTH.